Abbott reports Q3 worldwide Medical Devices sales up 16.6% on reported basis

Worldwide Medical Devices sales increased 16.6% on a reported basis and 14.7% on an organic basis in the third quarter. Sales growth was led by double-digit organic growth in Diabetes Care, Electrophysiology, Structural Heart, and Neuromodulation. Several recently launched products and new indications contributed to the strong performance, including Amplatzer Amulet, Navitor, TriClip, and AVEIR. In Electrophysiology, internationally, sales grew more than 20% on a reported and organic basis, which includes mid-teens growth in Europe. In Diabetes Care, FreeStyle Libre sales were $1.4B, which represents sales growth of 30.5% on a reported basis and 28.5% on an organic basis.